F.D.A. Approves Sickle Cell Treatments, Including One That Uses CRISPR
People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit its reach.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.